Serum Platelet-Activating Factor Acetylhydrolase Activity in Normal Pregnancy and Preeclampsia

References

• Roberts J M, Taylor R N, Musci T J, Rodgers G M, Hubel C A, McLaughlin M K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–4
   PubMed Web of Science ®Google Scholar
• Roberts J M, Taylor R N, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991; 4: 700–8
   PubMed Web of Science ®Google Scholar
• Baylis C, Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clin Exper Hyper Pregnancy 1992; B11(2&3)117–29
   Google Scholar
• Walsh S W. An imbalance in placental prostacyclin and thromboxane production. Am Obstet Gynecol 1985; 152: 335–40
   PubMed Web of Science ®Google Scholar
• Benveniste J, Henson P M, Cochrane C G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med 1972; 136: 1356–77
   PubMed Web of Science ®Google Scholar
• Camussi G, Bussolino F, Tetta C, Piacibello W, Aglietta M. Biosynthesis and release of platelet-activating factor from human monocytes. Int Arch Allergy Appl Immunol 1983; 70: 245–51
   PubMedGoogle Scholar
• Turner-Gomes S O, Bourdreau N, Rabinovitch M. Effect of ambient oxygen changes on platelet activating factor production by fetal ovine endothelial cells. Prostaglandins 1991; 41: 463–72
   PubMed Web of Science ®Google Scholar
• Issekutz A C, Szpejda M. Evidence that platelet activating factor may mediate some acute inflammatory responses. Lab Invest 1986; 54: 275–81
   PubMed Web of Science ®Google Scholar
• Hirafuji M, Shinoda H. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet activating factor in vitro. Br J Pharmacol 1991; 103: 1333–8
   PubMed Web of Science ®Google Scholar
• Blank M L, Hall M N. Inactivation of l-alkyl-2-acetyl-sn-glycero-3-phosphocholine by plasma acetylhydrolase: higher activities in hypertensive rats. Biochem Biophys Res Commun 1983; 113: 666–71
   PubMed Web of Science ®Google Scholar
• Crook J E, Mroczkowski P J, Cress E E, Blank M L, Snyder F. Serum platelet activating factor acetylhydrolase activity in white and black essential hypertensive patients. Circulation 1986; 74: 11–329
   Web of Science ®Google Scholar
• Zimmerman G A, McIntyre T M, Mehra M, Prescott S M. Endothelial cell-associated platelet-activating factor: A novel mechanism for signaling intercellular adhesion. J Cell Biol 1990; 110: 529–40
   PubMed Web of Science ®Google Scholar
• Mullane K M, Read N, Salmon J A, Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs. J Pharmacol Exp Ther 1984; 228: 510–22
   PubMed Web of Science ®Google Scholar
• Dembinska-Kiec A, Peskar B A, Muller M K, Peskar B M. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed. Prostaglandins 1989; 37: 69–91
   PubMed Web of Science ®Google Scholar
• Rodrigues A, Hofmeyr G J, Sonnendecker E WW, Atkunson P M. Hypothesis: a central role for platelet activating factor in the pathogenesis of pre-eclampsia. Med Hypotheses 1989; 28: 285–6
   PubMed Web of Science ®Google Scholar
• Benveniste J, Prefolani M. Paf-acether (platelet-activating-factor): its role in inflammation. Adv Inflam Res 1985; 10: 7–19
   Google Scholar
• Pinckard R N, Farr R S, Hanahan D J. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE-sensitized basophils. J Immunol 1979; 123: 1847–57
   PubMed Web of Science ®Google Scholar
• Farr R S, Wardlow M L, Cox C P, Meng K E, Greene D E. Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. Fed Proc 1983; 42: 3120–2
   PubMedGoogle Scholar
• Elstad M R, Stafforini D M, McIntyre T M, Prescott S M, Zimmerman G A. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. J Biol Chem 1989; 264: 8467–70
   PubMed Web of Science ®Google Scholar
• Miwa M. Catabolism of PAF and its regulation. Protein, Nucleic Acid and Enzyme 1991; 36: 352–62
   PubMedGoogle Scholar
• Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990; 259: 28, c697–c708, (Cell Physiol)
   Google Scholar
• Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Takamatsu S, Mizuno S, et al. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. Prostaglandins 1988; 35(3)685–98
   PubMed Web of Science ®Google Scholar
• Benedetto C, Massobrio M, Bertini E, Abbondanza M, Enrieu N, Tetta C. Reduced serum inhibition of platelet-activating factor activity in preeclampsia. Am J Obstet Gynecol 1989; 160: 100–4
   PubMed Web of Science ®Google Scholar
• Maki N, Magness R R, Miyaura S, Gant N F, Johnston J M. Platelet-activating factor acetylhydrolase activity in normotensive and hypertensive pregnancies. Am J Obstet Gynecol 1993; 168: 50–4
   PubMed Web of Science ®Google Scholar
• Cunningham F G, MacDonald P C, Gant N F, Leveno K J, Gilstrap L C, III. Hypertensive Disorders in Pregnancy: Williams Obstetrics. 19th ed. Appleton and Lange. 1993; 763–6
   Google Scholar
• Stafforini D M, Prescott S M, McIntyre T M. Human plasma platelet-activating factor acetylhydrolase. J Biol Chem. 1987; 262: 4223–30
   PubMed Web of Science ®Google Scholar
• Miwa M, Miyake T, Yamanaka T, Sugatani J, Suzuki Y, Sakata S, et al. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. J Clin Invest 1988; 82: 1983–91
   PubMed Web of Science ®Google Scholar